COVID-19 Agency Guidelines
Biomedical Advanced Research and Development Authority (BARDA)
3/9 – Due to the COVID-19 response, any white papers or full proposals submissions, other than those that are in support of COVID-19, will be put into a queue. The latest BARDA Broad Agency Announcement (BAA) is amendment 14.
Centers for Disease Control (CDC)
4/2 – Questions have been addressed in Responses to Top Questions from Responsible Parties Related to Coronavirus (COVID-19). These responses will be updated as needed. See the Support Materials page other documents.
Council on Governmental Relations (COGR)
For general information, visit COGR’s FAQs and Resources on COVID-19’s Impact to Federal Awards.
4/28 – A Federal Agency Guidance Matrix with several major grant-making agencies that will be updated weekly as additional guidance becomes available.
4/08 – FAQs Regarding COVID-19’s Impact to Federal Awards (V.2.2)
4/01 – COGR has updated their Frequently Asked Questions Regarding COVID-19’s Impact on Federal Awards (Version 2.1) to include updates to agency guidance.
3/16 – COGR’s notes from Call with Dr. Larry Tabak and Dr. Mike Lauer (NIH)
3/16 – COGR has issued a Frequently Asked Questions Regarding COVID-19’s Impact on Federal Awards (Version 1.1) and Frequently Asked Questions Regarding COVID-19’s Impact on Federal Awards (Version 2.0) representing their best assessment of an evolving situation based on already established policies and regulations.
Defense Advanced Research Projects Agency (DARPA)
3/19 – DARPA has posted a Frequently Asked Question (FAQ) about COVID-19 (Coronavirus) for DARPA Performers.
Department of Defense (DOD)
3/19 – Based on the OMB Memorandum, please find answers to Frequently Asked Questions by grantees and proposers about research and development awards at the DOD.
Department of Education (DoED)
4/8 – The Institute of Education Sciences (IES) has posted an FAQ About The Coronavirus Disease 2019 (COVID-19) for IES Grantees.
Department of Energy (DOE)
3/30 – DOE has posted PF 2020-20 COVID-19 Guidance for Financial Assistance Actions.
3/13 – As the DOE continues to monitor and examine the ongoing developments of the COVID-10 outbreak in the U.S. and internationally, they’ve provided an update regarding associated disruptions that may have impacts on the research community.
Department of Health and Human Services (HHS)
3/14 – HHS has issued a memorandum provides guidance on managing potential contract administration issues related to Coronavirus Disease 2019 (COVID-19).
Department of Justice (DOJ)
3/21 – The Office of Justice Programs (OJP) provides the following Guidance to Award Recipients Impacted by COVID-19: Short Term Relief for Various Administrative, Financial Management, and Audit Requirements on short term relief for various administrative, financial management, and audit requirements.
3/16 – OJP has issued OJP Grantee Update #1 COVID-19 Impacts that until further notice, pursuant to OMB Memorandum M-20-15, dated March 15, 2020, the Department of Justice is moving to a posture of maximum telework in the National Capital Region. Office of Justice Programs (OJP) staff will work remotely and will be available to assist grantees, stakeholders, and the public during this period. Likewise, all OJP systems and services will be available.
Department of the Air Force (DAF)
3/26 – The Air Force Office of Scientific Research (AFOSR) has issued a notice regarding Guidance on No Cost Extensions.
3/17 – The United States Air Force Academy (USAFA) has issued a notice regarding Potential Contract Impacts due to Coronavirus.
Department of the Navy (DON)
Health and Human Services (HHS)
For funding opportunities, visit Virus-Related Research Resources.
11/4 – Extended Guidance for Applicants Preparing Applications During the COVID-19 Pandemic
6/03 – FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency
3/26 – The Food and Drug Administration (FDA) has issued a notice is to alert the community of Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19.
3/26 – The Food and Drug Administration (FDA) has issued a notice to provide a second extension to the 2020 application due date for PAR-20-091 “Revision Applications – FSMA Human Foods Preventive Controls Implementation Expansion Supplement to RFA-FD-18-001 (U18 Clinical Trials Not Allowed).”
3/18 – The Food and Drug Administration (FDA) has issued a guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic.
National Aeronautics and Space Administration (NASA)
3/25 – NASA has posted a FAQ on Grants and Research during the COVID-19 Epidemic.
3/24 – NASA has issued a memo on Preserving Readiness of the Space Industrial Base and Mission Operational Readiness due to the Coronavirus (COVID-19) Situation.
3/20 – NASA has posted guidance and extensions on COVID-19 Impact to NASA SBIR/STTR Program.
3/17 – In a new NASA Administrator March 17 Statement on Agency Response to Coronavirus, NASA leadership has decided to elevate all centers and facilities to Stage 3 of NASA’s Response Framework. Effective immediately, all employees and contractors will move to mandatory telework until further notice.
3/10 – As the COVID-19 situation continues to evolve, NASA remains open but is taking precautions such as increasing telework opportunities according to an Assistant Administrator for Procurement Message.
National Institutes of Health (NIH)
For funding opportunities, visit Virus-Related Research Resources.
The NIH is committed to working with researchers and institutions to do all they can to ensure NIH-funded research continues. For the latest information, visit COVID-19: Information for NIH Applicants and Recipients and NIH Extramural Response to Natural Disasters and Other Emergencies and Applicant/Recipient COVID-19 Update History.
11/16 – Notice of NIA Withdrawal from Participation in NOT-MD-20-019 “Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities”
11/16 – Notice of NIA Withdrawal from Participation in NOT-MH-20-047 “Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus”
11/16 – Notice of NIA Withdrawal from Participation in NOT-OD-20-097 “Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences”
11/16 – Notice of NIA Withdrawal from Participation in NOT-MH-20-053, “Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19”
11/16 – Notice of NIA Withdrawal from Participation in NOT-MD-20-022, “Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations”
11/10 – Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome
7/02 – All COVID-19 FAQs are being revised to align with NIH Implementation of OMB Memorandum M-20-26, “Extension of Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations.”
6/25 – NIH Implementation of OMB Memorandum M-20-26 “Extension of Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations”
6/09 – With implementation of the President’s Guidelines for Re-Opening America Again, NIH, AHRQ, and NIOSH anticipate that many investigators may be able to generate preliminary data for those applications before peer review. Therefore, this Notice provides an exception to the NIH/AHRQ/NIOSH policy for post-submission materials (NOT-OD-19-083).
6/05 – Notice of NICHD Participation in NOT-EB-20-012 “Notice of Change in Application Due Date for PAR-19-215 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)”
5/11 – NIH Late Application Policy for Institutional Training Grants to PA-20-142 and PA-20-162 Due to Public Health Emergency for COVID-19
4/13 – The NIH has released guidance as to how to appropriately distinguish between, and submit to, the Emergency Competitive Revision FOA and the Urgent Competitive Revision FOA for COVID-19-related funding.
3/26 – NIH has posted an update on their NIH Late Application Policy Due to Public Health Emergency for United States for 2019 Novel Coronavirus.
3/26 – Dr. Mike Lauer, NIH Deputy Director for Extramural Research, has provided a video Update on COVID-19 Flexibilities for the Research Community.
3/17 – Dr. Mike Lauer, NIH Deputy Director for Extramural Research, has provided a video update for applicants and recipients of federal funding on flexibilities.
3/16 – NIH has posted a notice to inform institutions of Flexibilities for Activities of Institutional Animal Care and Use Committees that are applicable to implementing a pandemic plan for animal care and use programs.
3/16 – NIH has posted a notice to provide guidance outlining the flexibilities available to recipients conducting NIH-funded Clinical Trials and Human Subjects Studies that are impacted by the declared public health emergency for COVID-19.
3/13 – Are you testing or implementing your institution’s pandemic response plan for the first time? Do you have questions about flexibilities provided by the PHS Policy that may be helpful during a pandemic? NIH is hosting a special OLAW Webinar on March 19: Pandemic Contingency Planning and Its Impact on Animal Care.
3/12 – NIH has posted a notice to alert the community of Flexibilities Available to Applicants and Recipients of Federal Financial Assistance to assist with managing administrative, financial management and audit requirements.
3/10 – NIH has posted a notice to address General Frequently Asked Questions (FAQs) on Proposal Submission and Award Management that may arise in relation to COVID-19.
3/9 – It is likely that the emergency declaration will adversely affect some NIH applicants’ and recipients’ ability to submit applications in a timely manner. Learn about NIH’s Late Application Policy.
3/9 – NIH hosts a large number of scientific meetings and symposia so they’ve issued a guidance on Travel and Meetings Hosted by NIH during the outbreak.
National Science Foundation (NSF)
For funding opportunities, visit Virus-Related Research Resources.
For the latest NSF information visit Coronavirus Information.
6/25 – NSF has issued a guidance to implement updated guidance authorized by Office of Management and Budget (OMB) Memorandum M-20-261 for recipients affected by COVID-19.
6/24 – Proposers are advised that there has been an Impact on Existing Deadline Dates for some solicitations or Dear Colleague Letters (DCLs). Additional solicitations or DCLs may be added to the list, so proposers are strongly encouraged to check NSF’s website regularly.
5/19 – NSF Implementation of OMB Memorandum M-20-17, entitled, “Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations”
5/07 – Frequently Asked Questions (FAQs) About the Coronavirus Disease 2019 (COVID-19) for NSF Small Business Innovation Research Program (SBIR) and Small Business Technology Transfer Program (STTR) Grantees
4/10 – NSF has issued a guidance to implement the flexibility class exception authorized by OMB Memorandum M-20-20 that allows Federal awarding agencies to repurpose their Federal assistance awards (in whole or part) to support the COVID-19 response, as consistent with applicable laws.
4/10 – NSF has issued a Guidance on the Effects of COVID-19 on Vertebrate Animal Research.
4/6 – The following FAQ is for use by proposers to NSF DCL 20-052. Frequently Asked Questions (FAQs) regarding the NSF Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) (NSF 20-052)
4/1 – NSF has issued a revision to their implementation of the Office of Management and Budget (OMB) Memorandum (M-20-17), entitled, Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations.
3/31 – Frequently Asked Questions (FAQs) About the Coronavirus Disease 2019 (COVID-19) for Research Experiences for Undergraduates (REU) Sites, Research Experiences for Teachers (RET) Sites, International Research Experiences for Students (IRES) Sites, and Similar Activities
3/23 – NSF has posted a Letter to Community Regarding COVID-19.
3/9 – NSF has issued a statement that they are taking the following steps to reduce risks for travel, merit review panels and NSF-sponsored meetings while preserving their core mission.
3/9 – Considering inquiries received from managing organizations and contractors, NSF has issued guidance to entities managing major facilities under cooperative agreements or contracts issued by the Division of Acquisition and Cooperative Support (DACS).
3/5 – NSF is working closely with the research community to bolster our national response to COVID-19. Learn more about NSF Supporting Research to Address Coronavirus Disease.
National Security Agency (NSA)
Office of Management and Budget (OMB)
3/20 – OMB has issued Managing Federal Contract Performance Issues Associated with the Novel Coronavirus (COVID-19). This memorandum identifies steps to help ensure Federal contractors safety while maintaining continued contract performance in support of agency missions, wherever possible and consistent with the precautions issued by the Centers for Disease Control and Prevention (CDC).
3/19 – OMB has issued an Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations memorandum which provides similar administrative relief listed in M-20-11 to an expanded scope of recipients affected by the loss of operational capacity and increased costs due to the COVID-19 crisis.
3/9 – The Office of Management and Budget (OMB) has issued an Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) memorandum without compromising Federal financial assistance accountability requirements.
Office of Personnel Management (OPM)
The Office of Personnel Management (OPM) works closely with a number of federal agencies to provide updated information to Federal agencies and employees. They’ve shared a number of guidances on HR flexibilities and authorities related to COVID-19.
3/7 – Coronavirus Disease 2019 (COVID-19): Additional Guidance and Questions and Answers (PDF file) for Federal agencies regarding COVID-19 and human resources policies.
3/3 – Preliminary Guidance to Agencies during Coronavirus Disease 2019 (COVID-19) – Guidance on telework and Federal mission resilience, workplace safety, domestic travel and international travel for Federal employees, and visitor access to Federal offices and buildings.
2/7 – Human Resources Flexibilities Available for Federal Employees Impacted by the 2019 Novel Coronavirus – Guidance on human resources flexibilities and authorities, including leave and other paid time off, work schedule flexibilities, and hiring and pay flexibilities.
Substance Abuse and Mental Health Services Administration (SAMHSA)
United States Agency for International Development (USAID)
3/27 – OMB Memorandum M-20-17 provides administrative relief to recipients affected by the loss of operational capacity and increased costs due to the COVID-19 crisis. USAID has issued a memorandum authorizing COVID 19 flexibilities pursuant to OMB Memorandum M-20-17.
3/12 – USAID has issued the following guidance Information From the Office of Acquisition and Assistance in the Bureau for Management of the U.S. Agency for International Development.
United States Army Medical Research Acquisition Activity (USAMRAA)
3/26 – USAMRAA has posted COVID-19 FAQs for Grant Applicants and Recipients.
United States Department of Agriculture (USDA)/National Institute of Food and Agriculture (NIFA)
4/9 – NIFA has posted a guidance is to implement flexibilities authorized by Office of Management and Budget (OMB) Memorandum M-20-17. Learn more at NIFA-20-006 Implementation of OMB Memo M-20-17.
4/8 – NIFA has posted a FAQ about impacts of the COVID-19 emergency on USDA NIFA grants.
3/18 – Due to the disruptions arising from the national response to COVID-19, NIFA is extending some of their deadlines. NIFA will continue to monitor the situation and post updates to this guidance on their web site.
American Heart Association
Annie E. Casey Foundation
California Institute for Regenerative Medicine
Chan Zuckerberg Initiative
Council on Foundations
David and Lucile Packard Foundation
Harrington Discovery Institute
3/27 – Due to COVID-19, Harrington Discovery Institute is extending the deadline for the 2021 Harrington Scholar-Innovator call for letters of intent (LOI) to Friday, April 10.